Overview

S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
Patients with advanced esophageal cancer will receive thoracic radiation therapy 60Gy over 30 fractions,and concurrent with s-1 and nedaplatin.
Phase:
Phase 1
Details
Lead Sponsor:
Zhejiang Cancer Hospital
Treatments:
Nedaplatin